ACR适宜性标准®:肾移植功能障碍
肾移植是终末期肾病患者的首选治疗,5年生存率为72%至99%。超声是术后即刻和长期随访评估肾移植的一线影像方法,可显示多种并发症并引导治疗干预;核医学、CT和MRI常作为特定指征的补充检查,血管造影仍是血管并发症的参考标准并可引导非手术干预。美国放射学会适宜性标准基于文献证据,采用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗操作进行适宜性评级,证据不足时辅以专家意见。
要点
- 超声是肾移植术后即刻评估和长期随访的一线影像方法。
- 超声可显示多种移植肾并发症,并可引导治疗干预。
- 核医学、CT、MRI常作为特定指征的补充检查,血管造影是血管并发症的参考标准。
核心结论
- 超声是评估肾移植功能障碍的一线影像方法,可显示多种并发症并引导干预;核医学、CT和MRI为特定指征的补充检查,血管造影是血管并发症的参考标准并可引导非手术干预。
研究设计与样本
- 美国放射学会适宜性标准,由多学科专家小组每年审查,基于同行评议期刊文献的广泛分析,采用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗操作进行适宜性评级;证据不足或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
局限性
- 证据不足或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Renal transplantation is the treatment of choice in patients with end-stage renal disease because the 5-year survival rates range from 72% to 99%. Although graft survival has improved secondary to the introduction of newer immunosuppression drugs and the advancements in surgical technique, various complications still occur. Ultrasound is the first-line imaging modality for the evaluation of renal transplants in the immediate postoperative period and for long-term follow-up. In addition to depicting many of the potential complications of renal transplantation, ultrasound can also guide therapeutic interventions. Nuclear medicine studies, CT, and MRI are often helpful as complementary examinations for specific indications. Angiography remains the reference standard for vascular complications and is utilized to guide nonsurgical intervention. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Taffel MT, Nikolaidis P, Beland MD, et al. ACR Appropriateness Criteria® Renal Transplant Dysfunction. J Am Coll Radiol. 2017. PMID: 28473084. doi:10.1016/j.jacr.2017.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。